In this issue:
Mutations and treatment outcome in AML
MicroRNA expression in AML
Lenalidomide in relapsed and refractory CLL
Effects of imatinib on pregnancy
Nonmyeloablative SCT for relapsed follicular lymphoma
Induction of CD4+CD25+ T-reg by NHL
EPOCH and rituximab in DLBCL: analysis of biomarkers
CHOP plus rituximab and IFRT in limited-stage DLBCL
Clinical, biological and pathological features of AILT
Graft-versus-lymphoma effect in aggressive T-cell lymphomas
Please login below to download this issue (PDF)